November 4, 2025Announcement no. 21 Progress Update on BioPorto’s Adult Clinical Study Copenhagen, Denmark, November 4, 2025, (GLOBE NEWSWIRE) – BioPorto A/S (“BioPorto” or the “Company”) (CPH:BIOPOR), today announced an update on its ongoing adult clinical study in the US. At the end of October 2025, BioPorto successfully completed patient enrollment in its clinical cut-off study. The Company is in the process of collecting the study data, and this process is taking more time than initially anticipated. To ...